Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model

被引:82
作者
Chae, Michael [1 ]
Peterson, Timothy E. [1 ]
Balgeman, Alexis [1 ]
Chen, Selby [1 ]
Zhang, Lei [1 ]
Renner, Danielle N. [2 ]
Johnson, Aaron J. [2 ]
Parney, Ian F. [1 ]
机构
[1] Mayo Clin, Dept Neurol Surg, Rochester, MN USA
[2] Mayo Clin, Dept Immunol, Rochester, MN USA
关键词
glioma; GL261; immunosuppression; myeloid-derived suppressor cell; tumor-associated macrophage; REGULATORY T-CELLS; B7-H1; EXPRESSION; IMMUNE DEFECTS; IN-VITRO; TUMOR; GLIOBLASTOMA; VACCINATION; IMMUNOSUPPRESSION; DIFFERENTIATION; CYTOKINE;
D O I
10.1093/neuonc/nou343
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background. Patients with glioblastoma multiforme (GBM) exhibit marked intratumoral and systemic immunosuppression. GBM is heavily infiltrated with monocytic cells. Monocytes contacting GBM cells develop features of immunosuppressive myeloid-derived suppressor cells (MDSCs), which are elevated in GBM patients. Therefore, we hypothesized that circulating MDSC levels could be raised in vivo by increasing glioma-associated macrophages. Methods. GL261-luciferase glioma was implanted intracranially in C57BL/6 mice with or without additional normal syngeneic CD11b+ monocytes. Tumor growth and intratumoral and systemic MDSC (CD11b+/Gr-1+) levels were determined. Green fluorescent protein (GFP)-transgenic monocytes were coinjected intracranially with GL261-luciferase cells. GFP+ cell frequency among splenic and bone marrow MDSCs was determined. Impact of increased MDSC's on spontaneous immune responses to tumor cells expressing a model antigen (ovalbumin [ OVA]) was determined. Results. Tumors grew faster and MDSC's were increased in tumor, spleen, and bone marrow in mice receiving GL261-Luc plus monocytes. Many (30%-50%) systemic MDSC's were GFP+ in mice receiving intracranial tumor plus GFP-transgenic monocytes, suggesting that they originated from glioma-associated monocytes. Tumor-infiltrating OVA-specific CD8+ T cells were markedly reduced in mice receiving GL261-OVA and monocytes compared with mice receiving GL261-OVA alone. Conclusions. Increasing glioma-associated macrophages in intracranial GL261 glioma decreases survival and markedly increases intratumoral and systemic MDSC's, many of which originate directly from glioma-associated macrophages. This is associated with decreased spontaneous immune responses to a model antigen. To our knowledge, this is the first evidence in cancer that systemic MDSC's can arise directly from normal monocytes that have undergone intratumoral immunosuppressive education.
引用
收藏
页码:978 / 991
页数:14
相关论文
共 37 条
[1]
A CD8 T-Cell Epitope Variant Enhances Immune Targeting to a Recombinant Picornavirus Vaccine Antigen [J].
Bell, Michael P. ;
Renner, Danielle N. ;
Johnson, Aaron J. ;
Pavelko, Kevin D. .
VIRAL IMMUNOLOGY, 2014, 27 (07) :361-366
[2]
Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages [J].
Bloch, Orin ;
Crane, Courtney A. ;
Kaur, Rajwant ;
Safaee, Michael ;
Rutkowski, Martin J. ;
Parsa, Andrew T. .
CLINICAL CANCER RESEARCH, 2013, 19 (12) :3165-3175
[3]
A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment [J].
Cantini, Gabriele ;
Pisati, Federica ;
Mastropietro, Alfonso ;
Frattini, Veronique ;
Iwakura, Yoichiro ;
Finocchiaro, Gaetano ;
Pellegatta, Serena .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (12) :1739-1750
[4]
Immune defects observed in patients with primary malignant brain tumors [J].
Dix, AR ;
Brooks, WH ;
Roszman, TL ;
Morford, LA .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :216-232
[5]
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. [J].
Fecci, PE ;
Mitchell, DA ;
Whitesides, JF ;
Xie, WH ;
Friedman, AH ;
Archer, GE ;
Herndon, JE ;
Bigner, DD ;
Dranoff, G ;
Sampson, JH .
CANCER RESEARCH, 2006, 66 (06) :3294-3302
[6]
Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses [J].
Fricke, Ingo ;
Mirza, Noweeda ;
Dupont, Jakob ;
Lockhart, Craig ;
Jackson, Autumn ;
Lee, Ji-Hyun ;
Sosman, Jeffrey A. ;
Gabrilovich, Dmitry I. .
CLINICAL CANCER RESEARCH, 2007, 13 (16) :4840-4848
[7]
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells [J].
Fujita, Mitsugu ;
Kohanbash, Gary ;
Fellows-Mayle, Wendy ;
Hamilton, Ronald L. ;
Komohara, Yoshihiro ;
Decker, Stacy A. ;
Ohlfest, John R. ;
Okada, Hideho .
CANCER RESEARCH, 2011, 71 (07) :2664-2674
[8]
Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells-Significant Roles of CXCL10 [J].
Fujita, Mitsugu ;
Zhu, Xinmei ;
Ueda, Ryo ;
Sasaki, Kotaro ;
Kohanbash, Gary ;
Kastenhuber, Edward R. ;
McDonald, Heather A. ;
Gibson, Gregory A. ;
Watkins, Simon C. ;
Muthuswamy, Ravikumar ;
Kalinski, Pawel ;
Okada, Hideho .
CANCER RESEARCH, 2009, 69 (04) :1587-1595
[9]
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone [J].
Gustafson, Michael P. ;
Lin, Yi ;
New, Kent C. ;
Bulur, Peggy A. ;
O'Neill, Brian Patrick ;
Gastineau, Dennis A. ;
Dietz, Allan B. .
NEURO-ONCOLOGY, 2010, 12 (07) :631-644
[10]
Hao CH, 2002, ACTA NEUROPATHOL, V103, P171